Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01020019 CE(22:4) cPLA2i 1.0 BCD110605C28 28.6 pmol/sample
LMST01020019 CE(22:4) cPLA2i 1.0 BCD110605C30 2.42 pmol/sample
LMST01020019 CE(22:4) cPLA2i 1.0 BCD110605C29 8.42 pmol/sample
LMST01020019 CE(22:4) cPLA2i 20.0 BCD110605C64 10.8 pmol/sample
LMST01020019 CE(22:4) cPLA2i 20.0 BCD110605C66 2.43 pmol/sample
LMST01020019 CE(22:4) cPLA2i 20.0 BCD110605C65 7.02 pmol/sample
LMST01020019 CE(22:4) PLDi 1.0 BCD110605C16 24.9 pmol/sample
LMST01020019 CE(22:4) PLDi 1.0 BCD110605C18 5.12 pmol/sample
LMST01020019 CE(22:4) PLDi 1.0 BCD110605C17 13.2 pmol/sample
LMST01020019 CE(22:4) PLDi 20.0 BCD110605C54 3.85 pmol/sample
LMST01020019 CE(22:4) PLDi 20.0 BCD110605C53 3.92 pmol/sample
LMST01020019 CE(22:4) PLDi 20.0 BCD110605C52 6.91 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 1.0 BCD110605C32 7.33 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 1.0 BCD110605C31 16.4 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 1.0 BCD110605C33 6.32 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 20.0 BCD110605C68 7.69 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 20.0 BCD110605C69 4.88 pmol/sample
LMST01020019 CE(22:4) KDO+cPLA2i 20.0 BCD110605C67 11.2 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 1.0 BCD110605C19 12.9 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 1.0 BCD110605C20 7.11 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 1.0 BCD110605C21 4.28 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 20.0 BCD110605C57 3.65 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 20.0 BCD110605C55 10.3 pmol/sample
LMST01020019 CE(22:4) KDO+PLDi 20.0 BCD110605C56 4.13 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 1.0 BCD110605C38 7.23 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 1.0 BCD110605C37 18.2 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 1.0 BCD110605C39 5.57 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 20.0 BCD110605C74 11.6 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 20.0 BCD110605C73 13.3 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+cPLA2i 20.0 BCD110605C75 3.29 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 1.0 BCD110605C26 6.77 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 1.0 BCD110605C27 4.04 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 1.0 BCD110605C25 11.2 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 20.0 BCD110605C62 2.58 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 20.0 BCD110605C63 5.49 pmol/sample
LMST01020019 CE(22:4) KDO+ATP+PLDi 20.0 BCD110605C61 7.39 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 1.0 BCD110605C15 5.27 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 1.0 BCD110605C13 20.4 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 1.0 BCD110605C14 10.7 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 20.0 BCD110605C51 4.83 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 20.0 BCD110605C49 10.1 pmol/sample
LMST01020019 CE(22:4) KDO + ATP 20.0 BCD110605C50 4.45 pmol/sample
LMST01020019 CE(22:4) KDO 1.0 BCD110605C09 7.33 pmol/sample
LMST01020019 CE(22:4) KDO 1.0 BCD110605C08 6.7 pmol/sample
LMST01020019 CE(22:4) KDO 1.0 BCD110605C07 17.7 pmol/sample
LMST01020019 CE(22:4) KDO 20.0 BCD110605C43 8.07 pmol/sample
LMST01020019 CE(22:4) KDO 20.0 BCD110605C44 5.22 pmol/sample
LMST01020019 CE(22:4) KDO 20.0 BCD110605C45 4.46 pmol/sample
LMST01020019 CE(22:4) C 0.0 BCD110605C03 8.92 pmol/sample
LMST01020019 CE(22:4) C 0.0 BCD110605C02 18.4 pmol/sample